Rule 30 – Requirements of European patent applications relating to nucleotide and amino acid sequences - The European Patent Convention, Implementing Regulations – to the Convention on the Grant of European Patents, Part II – Implementing Regulations to Part II of the Convention, Chapter V – Biotechnological inventions
New look and feel for EPO website
We have redesigned the EPO website to give it a new look and feel. To ensure that the new layout is displayed correctly by your browser(s), we recommend you clear your browser cache.
If nucleotide or amino acid sequences are disclosed in the European patent application, the description shall contain a sequence listing conforming to the rules laid down by the President of the European Patent Office for the standardised representation of nucleotide and amino acid sequences.
A sequence listing filed after the date of filing shall not form part of the description.
Where the applicant has not filed a sequence listing complying with the requirements under paragraph 1 at the date of filing, the European Patent Office shall invite the applicant to furnish such a sequence listing and pay the late furnishing fee. If the applicant does not furnish the required sequence listing and pay the required late furnishing fee within a period of two months after such an invitation, the application shall be refused.